Abbott Laboratories is betting heart patients will benefit from a new type of arterial stent that dissolves away when it is no longer needed. Get the full story »
Inside these posts: Heart stents
Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
Johnson & Johnson recalls insulin cartridges
Johnson & Johnson, which has been beset by a seemingly endless stream of product recalls, has recalled five lots of potentially leaky insulin pump cartridges that could lead to serious health problems and death.
It also has been warned by the Food and Drug Administration over manufacturing concerns for heart devices made at its Cordis unit’s San German, Puerto Rico facility. Get the full story »
Abbott’s Acculink stent trial met goals, FDA says
Abbott Laboratories’ RX Acculink carotid stent appears to work as well as surgery in opening clogged neck arteries in patients who are not at high risk for complications from the surgical procedure, U.S. health regulatory staff concluded.
The device is already approved for patients who need to have their neck arteries opened up, but would face greater risk of side effects if they underwent a procedure to scrape off built-up fatty deposits that can cause strokes. Get the full story »
Abbott absorbable heart stent gets European OK
Abbott Laboratories’ said its experimental dissolvable heart stent has received approval in Europe, a key milestone in the development of the next-generation heart device for patients in the U.S. and around the world.
The North Chicago-based drug and medical device giant said it is the first-ever government regulatory approval of an absorbable stent. Get the full story »
